+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Safety and outcomes of balloon catheter sinusotomy: a multicenter 24-week analysis in 115 patients

Safety and outcomes of balloon catheter sinusotomy: a multicenter 24-week analysis in 115 patients

Otolaryngology--Head and Neck Surgery 137(1): 10-20

The aim of this study was to further evaluate the safety and effectiveness of balloon catheter devices to dilate obstructed sinus ostia/perform sinusotomy. Through a prospective, multicenter evaluation, safety was assessed by rate of adverse events, patency was determined by endoscopic examination, and sinus symptoms were determined by the Sino-Nasal Outcome Test (SNOT 20). At the conclusion of the 24-week analysis, endoscopy determined that the sinusotomy was patent in 80.5% (247 of 307) sinuses and nonpatent in 1.6% (5 of 307), and could not determine ostial patency status in 17.9% (55 of 307). Of the ostia visualized on endoscopy, 98% were patent (247 of 252), while 2% (5 of 252) were considered nonpatent. SNOT 20 scores showed consistent symptomatic improvement over baseline. Revision treatment was required in 3 sinuses (3 of 307 sinuses, 0.98%) in 3 patients (3 of 109 patients, 2.75%). Balloon catheter technology appears safe and effective in relieving ostial obstruction. Patients were pleased and indicated that they experienced symptomatic improvement.

(PDF emailed within 0-6 h: $19.90)

Accession: 055643178

Download citation: RISBibTeXText

PMID: 17599558

DOI: 10.1016/j.otohns.2007.02.006

Related references

Multicenter registry of balloon catheter sinusotomy outcomes for 1,036 patients. Annals of Otology, Rhinology, and Laryngology 117(4): 263-270, 2008

Balloon catheter sinusotomy: one-year follow-up--outcomes and role in functional endoscopic sinus surgery. Otolaryngology--Head and Neck Surgery 139(3 Suppl 3): S27-S37, 2008

Long-term outcome analysis of balloon catheter sinusotomy: two-year follow-up. Otolaryngology--Head and Neck Surgery 139(3 Suppl 3): S38-S46, 2008

Balloon catheter sinusotomy. Otolaryngology--Head and Neck Surgery 138(1): 126; Author Reply 126-7, 2008

Safety and feasibility of the IVUS-Balloon Megasonics catheter A multicenter investigation. Journal of the American College of Cardiology 37(2 Supplement A): 79A, February, 2001

Multicenter study on the safety and feasibility of the intravenous ultrasound-balloon megasonics catheter. American Journal of Cardiology 86(Suppl 8A): 102i-103i, October 16, 2000

Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study. Journal of Dermatology 43(9): 1011-1017, 2016

Duplex outcomes of the CryoVascular Peripheral Balloon Catheter System Safety Registry. Journal of the American College of Cardiology 43(5 Supplement A): 100A, March 3, 2004

A multicenter, open-label, 24-week study with a 24-week extension to evaluate the efficacy and safety of indinavir sulfate 800 mg and ritonavir 200 mg bid Plus 2 NRTIs bid in HIV-1 infected individuals failing initial PI therapy 48Wk analysis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 264, 2002

Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study. Arthritis and Rheumatism 58(7): 1921-1930, 2008

A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. American Heart Journal 166(3): 527-533, 2013

Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial. Journal of Acquired Immune Deficiency Syndromes 62(2): 171-179, 2013

Bicyclic eremophilane-type petasite sesquiterpenes potentiate peroxisome proliferator-activated receptor γ activator-mediated inhibition of dendritic cells. International Journal of Immunopathology and Pharmacology 32: 2058738418787739-2058738418787739, 2018

Comparative evaluation of two ELISA kits for detecting antibodies to a nonstructural protein of foot-and-mouth disease virus using serum samples collected from naturally and experimentally infected cows. Journal of Veterinary Medical Science, 2018

Safety and outcomes following hybrid balloon and balloon-only procedures using a multifunction, multisinus balloon dilation tool. International Forum of Allergy & Rhinology 3(8): 652-658, 2014